Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Acute Kidney Injury | Research article

Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia

Authors: Dawei Chen, Hongbo Yuan, Changchun Cao, Zhihe Liu, Linglin Jiang, Yan Tan, Ji Ding, Mengqing Ma, Wenjuan Huang, Xin Wan

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Acute kidney injury (AKI) is a frequent complication of community acquired pneumonia (CAP). However, the impact of AKI on in-hospital outcomes of patients with CAP in the Chinese population remains unclear.

Methods

Patients diagnosed with CAP were evaluated in this retrospective observational study. Multiple Cox regression models were employed to identify the association between AKI and in-hospital mortality and 30-day mortality, respectively.

Results

A total of 4213 patients were recruited; 950 (22.5%) patients were diagnosed with AKI. Independent risk factors for AKI were age, male gender, hypertension, cardiac dysfunction, diabetes, chronic kidney disease, acute respiratory failure, use of diuretics, use of vasoactive drugs, and CURB-65. Cox proportional hazards regression revealed AKI, use of angiotensin receptor blocker, hypertension, CURB-65, acute respiratory failure, and use of vasoactive drugs to be independent risk factors for both in-hospital and 30-day mortality. Compared to patients without AKI, those suffering AKI were found to have 1.31-fold (HR 1.31, 95% CI, 1.04–1.66; P = 0.023) and 1.29-fold (HR 1.29, 95% CI, 1.02–1.62; P = 0.033) increased in-hospital and 30-day mortality risks, respectively. In addition, patients with AKI were likely to require admission to intensive care unit (ICU) (42.9% versus 11.4%; P < 0.001), mechanical ventilation (33.8% versus 9.3%; P < 0.001), invasive mechanical ventilation (25.9% versus 5.8%; P < 0.001), non-invasive mechanical ventilation (25.4% versus 7.1%; P < 0.001), and experienced a longer duration of hospital stay (14 days versus 10 days; P < 0.001) than those without AKI. However, no significant difference in ICU stay (11 days versus 10 days; P = 0.099) and duration of mechanical ventilation (8 days versus 8 days; P = 0.369) between AKI and non-AKI groups was found.

Conclusion

AKI was common in Chinese patients with CAP. Patients with CAP who developed AKI had worse in-hospital outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, Agrawal A, Ahmadi A. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–210.CrossRef Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, Agrawal A, Ahmadi A. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–210.CrossRef
2.
go back to reference Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.CrossRef Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.CrossRef
3.
go back to reference Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347–82.CrossRef Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347–82.CrossRef
4.
go back to reference Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835–45.CrossRef Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835–45.CrossRef
5.
go back to reference Chen L, Zhou F, Li H, et al. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open. 2018;8:e018709.CrossRef Chen L, Zhou F, Li H, et al. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open. 2018;8:e018709.CrossRef
6.
go back to reference Akram AR, Singanayagam A, Choudhury G, et al. Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia. Chest. 2010;138:825–32.CrossRef Akram AR, Singanayagam A, Choudhury G, et al. Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia. Chest. 2010;138:825–32.CrossRef
7.
go back to reference Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77:527–35.CrossRef Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77:527–35.CrossRef
8.
go back to reference Murugan R, Weissfeld L, Yende S, et al. Association of statin use with risk and outcome of acute kidney injury in community-acquired pneumonia. Clin J Am Soc Nephrol. 2012;7:895–905.CrossRef Murugan R, Weissfeld L, Yende S, et al. Association of statin use with risk and outcome of acute kidney injury in community-acquired pneumonia. Clin J Am Soc Nephrol. 2012;7:895–905.CrossRef
9.
go back to reference Chawla LS, Amdur RL, Faselis C, et al. Impact of acute kidney injury in patients hospitalized with pneumonia. Crit Care Med. 2017;45:600–6.CrossRef Chawla LS, Amdur RL, Faselis C, et al. Impact of acute kidney injury in patients hospitalized with pneumonia. Crit Care Med. 2017;45:600–6.CrossRef
10.
go back to reference Luo Q, Ning P, Zheng Y, et al. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. Crit Care. 2018;22:15.CrossRef Luo Q, Ning P, Zheng Y, et al. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. Crit Care. 2018;22:15.CrossRef
11.
go back to reference Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.CrossRef Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.CrossRef
12.
go back to reference Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.CrossRef Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.CrossRef
13.
go back to reference Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.CrossRef Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.CrossRef
14.
go back to reference Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193–207.CrossRef Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193–207.CrossRef
15.
go back to reference Aliberti S, Brambilla AM, Chalmers JD, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res. 2014;15:27.CrossRef Aliberti S, Brambilla AM, Chalmers JD, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res. 2014;15:27.CrossRef
16.
go back to reference Soto GJ, Frank AJ, Christiani DC, et al. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med. 2012;40:2601–8.CrossRef Soto GJ, Frank AJ, Christiani DC, et al. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med. 2012;40:2601–8.CrossRef
17.
go back to reference Haneya A, Diez C, Philipp A, et al. Impact of acute kidney injury on outcome in patients with severe acute respiratory failure receiving extracorporeal membrane oxygenation. Crit Care Med. 2015;43:1898–906.CrossRef Haneya A, Diez C, Philipp A, et al. Impact of acute kidney injury on outcome in patients with severe acute respiratory failure receiving extracorporeal membrane oxygenation. Crit Care Med. 2015;43:1898–906.CrossRef
18.
go back to reference Ballèvre L, Thonney M, Guignard JP. Role of nitric oxide in the hypoxemia-induced renal dysfunction of the newborn rabbit. Pediatr Res. 1996;39:725–30.CrossRef Ballèvre L, Thonney M, Guignard JP. Role of nitric oxide in the hypoxemia-induced renal dysfunction of the newborn rabbit. Pediatr Res. 1996;39:725–30.CrossRef
19.
go back to reference Huet F, Semama DS, Gouyon JB, et al. Protective effect of perindoprilat in the hypoxemia-induced renal dysfunction in the newborn rabbit. Pediatr Res. 1999;45:138–42.CrossRef Huet F, Semama DS, Gouyon JB, et al. Protective effect of perindoprilat in the hypoxemia-induced renal dysfunction in the newborn rabbit. Pediatr Res. 1999;45:138–42.CrossRef
20.
go back to reference Domenech P, Perez T, Saldarini A, et al. Kidney–lung pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol. 2017;49:1211–5.CrossRef Domenech P, Perez T, Saldarini A, et al. Kidney–lung pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol. 2017;49:1211–5.CrossRef
21.
go back to reference Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med. 2020;46:654–72.CrossRef Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med. 2020;46:654–72.CrossRef
22.
go back to reference Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically Ill patient. Am J Respir Crit Care Med. 2016;194:402–14.CrossRef Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically Ill patient. Am J Respir Crit Care Med. 2016;194:402–14.CrossRef
23.
go back to reference Doi K, Ishizu T, Fujita T, et al. Lung injury following acute kidney injury: kidney-lung crosstalk. Clin Exp Nephrol. 2011;15:464–70.CrossRef Doi K, Ishizu T, Fujita T, et al. Lung injury following acute kidney injury: kidney-lung crosstalk. Clin Exp Nephrol. 2011;15:464–70.CrossRef
24.
go back to reference Visconti L, Santoro D, Cernaro V, et al. Kidney-lung connections in acute and chronic diseases: current perspectives. J Nephrol. 2016;29:341–8.CrossRef Visconti L, Santoro D, Cernaro V, et al. Kidney-lung connections in acute and chronic diseases: current perspectives. J Nephrol. 2016;29:341–8.CrossRef
25.
go back to reference Ranieri VM, Giunta F, Suter PM, et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284:43–4.CrossRef Ranieri VM, Giunta F, Suter PM, et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284:43–4.CrossRef
26.
go back to reference Husain-Syed F, Rosner MH, Ronco C. Distant organ dysfunction in acute kidney injury. Acta Physiol (Oxf). 2020;228:e13357.CrossRef Husain-Syed F, Rosner MH, Ronco C. Distant organ dysfunction in acute kidney injury. Acta Physiol (Oxf). 2020;228:e13357.CrossRef
27.
go back to reference Lee SA, Cozzi M, Bush EL, et al. Distant organ dysfunction in acute kidney injury: a review. Am J Kidney Dis. 2018;72:846–56.CrossRef Lee SA, Cozzi M, Bush EL, et al. Distant organ dysfunction in acute kidney injury: a review. Am J Kidney Dis. 2018;72:846–56.CrossRef
28.
go back to reference Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int. 2016;89:555–64.CrossRef Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int. 2016;89:555–64.CrossRef
29.
go back to reference Kao CC, Yang WS, Fang JT, et al. Remote organ failure in acute kidney injury. J Formos Med Assoc. 2019;118:859–66.CrossRef Kao CC, Yang WS, Fang JT, et al. Remote organ failure in acute kidney injury. J Formos Med Assoc. 2019;118:859–66.CrossRef
30.
go back to reference Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.CrossRef Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.CrossRef
31.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.CrossRef
Metadata
Title
Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia
Authors
Dawei Chen
Hongbo Yuan
Changchun Cao
Zhihe Liu
Linglin Jiang
Yan Tan
Ji Ding
Mengqing Ma
Wenjuan Huang
Xin Wan
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01511-9

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.